Aetna price target raised to $75 from $65 at Cantor

Cantor raised its price target on Aetna to $75 citing the company's progress over the past year and the firm's belief that the Coventry purchase significantly enhances the company's government business. The firm maintains its Hold rating on the stock, citing uncertainty about rates and utilization headwinds.